|
|
Article: Clinic Roundup.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Auxilium Pharmaceuticals Inc., of Malvern, Pa., received clearance from the FDA to resume its phase III clinical trials for Xiaflex (clostridial collagenase for injection) in the treatment of Dupuytren's contracture, a condition that involves contracture of joints in the hand that impairs patients' ability to straighten and move their fingers due to a thickening and shortening of the normal ligaments of the palm and fingers. The company plans to begin enrolling patients within a month.
o Bioniche Life Sciences Inc., of Belleville, Ontario, said a full complement of 25 sites have been qualified to enroll patients in its clinical trial with Mycobacterial Cell ...